Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1938]
News [3134]
Articles [127]
Editorials [3]
Conferences [120]
elearning [13]
Early platelet drop in myelodysplastic syndrome highlights prognostic classifier
Dr Raphael Itzykson - Hopital Saint-Louis, Paris Diderot University, Paris...
Early platelet drop in myelodysplastic syndrome highlights prognostic classifier ( Dr Raphael Itzykson - Hopital Saint-Louis, Paris Diderot University, Paris, France )
10 Dec 2017
Six-month follow up of CTL019 for diffuse large B-cell lymphoma
Dr Stephen Schuster - University of Pennsylvania, Philadelphia, USA
Six-month follow up of CTL019 for diffuse large B-cell lymphoma ( Dr Stephen Schuster - University of Pennsylvania, Philadelphia, USA )
10 Dec 2017
New treatment strategies for multiple myeloma
Dr James Kochenderfer - National Cancer Institute, Bethesda, USA
New treatment strategies for multiple myeloma ( Dr James Kochenderfer - National Cancer Institute, Bethesda, USA )
10 Dec 2017
Anti-BCMA CAR T cell therapy for multiple myeloma
Dr James Kochenderfer - National Cancer Institute, Bethesda, USA
Anti-BCMA CAR T cell therapy for multiple myeloma ( Dr James Kochenderfer - National Cancer Institute, Bethesda, USA )
10 Dec 2017
Axicabtagene ciloleucel for patients with non-hodgkin lymphoma
Dr Sattva Neelapu - MD Anderson Cancer Center, Houston, USA
Axicabtagene ciloleucel for patients with non-hodgkin lymphoma ( Dr Sattva Neelapu - MD Anderson Cancer Center, Houston, USA )
10 Dec 2017
Data from the CLARITY trial of ibrutinib plus venetoclax
Prof Peter Hillmen - University of Leeds, Leeds, UK
Data from the CLARITY trial of ibrutinib plus venetoclax ( Prof Peter Hillmen - University of Leeds, Leeds, UK )
10 Dec 2017
Mogamulizumab for cutaneous T- cell lymphoma
Prof Youn Kim - Stanford University, Stanford, CA
Mogamulizumab for cutaneous T- cell lymphoma ( Prof Youn Kim - Stanford University, Stanford, CA )
10 Dec 2017
Phase 1 study of Blu-285 in advanced systemic mastocytosis
Prof Daniel DeAngelo - Dana-Farber Cancer Institute, Boston, USA
Phase 1 study of Blu-285 in advanced systemic mastocytosis ( Prof Daniel DeAngelo - Dana-Farber Cancer Institute, Boston, USA )
10 Dec 2017
Ibrutinib plus venetoclax for previously treated CLL: CLARITY trial
Prof Peter Hillmen - University of Leeds, Leeds, UK
Ibrutinib plus venetoclax for previously treated CLL: CLARITY trial ( Prof Peter Hillmen - University of Leeds, Leeds, UK )
10 Dec 2017
Data from the JULIET trial of CTL019 for relapsed or refractory diffuse large B...
Dr Stephen Schuster - University of Pennsylvania, Philadelphia, USA
Data from the JULIET trial of CTL019 for relapsed or refractory diffuse large B-cell lymphoma ( Dr Stephen Schuster - University of Pennsylvania, Philadelphia, USA )
10 Dec 2017
Brentuximab vedotin for advanced Hodgkin lymphoma in the ECHELON-1 study
Dr Joseph Connors - British Columbia Cancer Agency, Vancouver, Canada
Brentuximab vedotin for advanced Hodgkin lymphoma in the ECHELON-1 study ( Dr Joseph Connors - British Columbia Cancer Agency, Vancouver, Canada )
10 Dec 2017
New treatments for acute myeloid leukaemia
Dr Anna Halpern - Seattle Cancer Care Alliance, Seattle, USA
New treatments for acute myeloid leukaemia ( Dr Anna Halpern - Seattle Cancer Care Alliance, Seattle, USA )
10 Dec 2017

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation